Therefore, these results indicate that P4HA1 expression was associated with unfavorable clinicopathological characteristics in patients with pancreatic cancer and might play a detrimental role in pancreatic cancer. The gene discussed is P4HA1; the disease is familial pancreatic carcinoma.